Universität Wien

270041 VO Medical Radiochemistry II (2023S)

Tracer Development - from Bench to Bed

4.00 ECTS (2.00 SWS), SPL 27 - Chemie
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: German

Examination dates

Lecturers

Classes (iCal) - next class is marked with N

  • Thursday 23.03. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
  • Tuesday 28.03. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
  • Thursday 30.03. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
  • Tuesday 18.04. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
  • Thursday 20.04. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
  • Tuesday 25.04. 16:00 - 17:30 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
  • Thursday 27.04. 16:00 - 17:30 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
  • Tuesday 02.05. 16:00 - 17:30 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
  • Thursday 04.05. 16:00 - 17:30 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
  • Tuesday 09.05. 16:00 - 17:30 Kleiner Hörsaal 3 Chemie Boltzmanngasse 1 HP
  • Thursday 11.05. 16:00 - 17:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1

Information

Aims, contents and method of the course

-Basics in radiopharmaceutical sciences, preclinical evaluation and nuclear medicine
-Pharmacokinetics and Modelling
-Special Challenges in neuro-radiopharmaceutical development (blood brain barrier)
- Methods of radiopharmaceutical drug development and process
-Radiopharmaceuticals for diagnostic, therapeutic use and developments in neuroimaging
-Preclinical studies (in vitro, animal studies) and clinical studies

Assessment and permitted materials

Multiple Choice Test (written/online), teaching material permitted

3 Dates (13.06.22 & 29.06.22 & 26.09)

Minimum requirements and assessment criteria

>50% correct answers to pass exam
-To learn about the most important pharmacological criteria in radiopharmaceutical drug development
-To know the most important radiopharmaceuticals for nuclear medicine
-To hear about important methods in drug development
-To understand essentials in (radio)pharmacological behavior
-To understand the theranostic concept
-To understand preclinical and clinical study designs (development process)

Examination topics

See above, minimum requirements and assessment criteria

Reading list

1. "Handbook of Radiopharmaceuticals" von Michael Welch und Carol S. Redvanly
2. "Radiopharmaceuticals: in Nuclear Pharmacy and Nuclear Medicine" von Richard J., Ph.D. Kowalsky, Steven W., Ph.D. Falen
3. . ETH ZÜRICH - RADIOPHARMAZEUTISCHE CHEMIE http://www.pharma.ethz.ch/institute_groups/radiopharmaceutical_science/lectures/index
4. Universität Würzburg - KURSUS DER NUKLEARMEDIZIN http://www.uni-wuerzbrug.de/nuklearmedizin/kursus/Kursus.htm
5. 5. The role of radiopharmaceuticals in drug discovery and development. Kairemo K. Curr Pharm Des. 2009;15(9):926-7
6. Molecular Imaging with PET. Ametamey S, Honer M, Schubiger PA, Chem. Rev. 2008, 108, 1501–1516
7. Animal Models for Human Cancer, Edited by Marianne I. Martic-Kehl and P. August Schubiger, Dicovery and Development of Novel Therapeutics, Volume 69

Association in the course directory

AC-4, CH-CBS-08, BC-Wahl

Last modified: Tu 04.07.2023 10:07